Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Dow
Harvard Business School
Express Scripts
McKinsey

Last Updated: August 19, 2022

Details for New Drug Application (NDA): 020873


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 020873 describes ANGIOMAX, which is a drug marketed by Sandoz Inc and Maia Pharms Inc and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ANGIOMAX profile page.

The generic ingredient in ANGIOMAX is bivalirudin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
Summary for 020873
Tradename:ANGIOMAX
Applicant:Sandoz Inc
Ingredient:bivalirudin
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 020873
Mechanism of Action Thrombin Inhibitors
Suppliers and Packaging for NDA: 020873
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANGIOMAX bivalirudin INJECTABLE;INTRAVENOUS 020873 NDA AUTHORIZED GENERIC Sandoz Inc 0781-3158 0781-3158-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3158-95) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0781-3158-94)
ANGIOMAX bivalirudin INJECTABLE;INTRAVENOUS 020873 NDA Sandoz Inc 0781-3447 0781-3447-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3447-95) > 1 INJECTION in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength250MG/VIAL
Approval Date:Dec 15, 2000TE:APRLD:Yes
Patent:See Plans and PricingPatent Expiration:Jan 27, 2029Product Flag?Substance Flag?Delist Request?Y
Patent:See Plans and PricingPatent Expiration:Jan 27, 2029Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Medtronic
Moodys
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.